Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes

References

• Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics—2021 update. Circulation. 2021;143:8. doi:10.1161/CIR.0000000000000950
   Web of Science ®Google Scholar
• Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases. Circulation. 2001;104(22):2746–2753. doi:10.1161/hc4601.099487
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cardiovascular diseases (CVDs); 2021. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed June 20, 2022.
   Google Scholar
• Matkar PN, Leong-Poi H, Singh KK. Cardiac gene therapy: are we there yet? Gene Ther. 2016;23(8–9):635–648. doi:10.1038/gt.2016.43
   PubMed Web of Science ®Google Scholar
• Tarride JE, Lim M, DesMeules M, et al. A review of the cost of cardiovascular disease. Canadian J Cardiol. 2009;25(6):e195–e202. doi:10.1016/S0828-282X(09)70098-4
   PubMedGoogle Scholar
• Tilemann L, Ishikawa K, Weber T, Hajjar RJ. Gene therapy for heart failure. Circ Res. 2012;110(5):777–793. doi:10.1161/CIRCRESAHA.111.252981
   PubMed Web of Science ®Google Scholar
• Boon RA, Dimmeler S. MicroRNAs in myocardial infarction. Nat Rev Cardiol. 2015;12(3):135–142. doi:10.1038/nrcardio.2014.207
   PubMed Web of Science ®Google Scholar
• Cannatà A, Ali H, Sinagra G, Giacca M. Gene therapy for the heart lessons learned and future perspectives. Circ Res. 2020;126(10):1394–1414. doi:10.1161/CIRCRESAHA.120.315855
   PubMed Web of Science ®Google Scholar
• Gabisonia K, Prosdocimo G, Aquaro GD, et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature. 2019;569(7756):418–422. doi:10.1038/s41586-019-1191-6
   PubMed Web of Science ®Google Scholar
• Lyon AR, Sato M, Hajjar RJ, Samulski RJ, Harding SE. Gene therapy: targeting the myocardium. Heart. 2008;94(1):89–99. doi:10.1136/hrt.2007.116483
   PubMed Web of Science ®Google Scholar
• Mason D, Chen YZ, Krishnan HV, Sant S. Cardiac gene therapy: recent advances and future directions. J Controlled Release. 2015;215:101–111. doi:10.1016/j.jconrel.2015.08.001
   PubMed Web of Science ®Google Scholar
• Sasano T, Kikuchi K, McDonald AD, Lai S, Donahue JK. Targeted high-efficiency, homogeneous myocardial gene transfer. J Mol Cell Cardiol. 2007;42(5):954–961. doi:10.1016/j.yjmcc.2007.02.004
   PubMed Web of Science ®Google Scholar
• Nayak S, Herzog RW. Progress and prospects: immune responses to viral vectors. Gene Ther. 2010;17(3):295–304. doi:10.1038/gt.2009.148
   PubMed Web of Science ®Google Scholar
• Ji J, Shang-Yi Y. Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement. Int J Nanomedicine. 2012:2911. doi:10.2147/IJN.S32363
   PubMed Web of Science ®Google Scholar
• Sun L, Huang CW, Wu J, et al. The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium. Biomaterials. 2013;34(8):2107–2116. doi:10.1016/j.biomaterials.2012.11.041
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28–51. doi:10.1016/j.addr.2015.09.012
   PubMed Web of Science ®Google Scholar
• Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15(8):541–555. doi:10.1038/nrg3763
   PubMed Web of Science ®Google Scholar
• Guimaraes PPG, Zhang R, Spektor R, et al. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening. J Controlled Release. 2019;316:404–417. doi:10.1016/j.jconrel.2019.10.028
   PubMed Web of Science ®Google Scholar
• Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Materials. 2021;6(12):1078–1094. doi:10.1038/s41578-021-00358-0
   PubMed Web of Science ®Google Scholar
• Bus T, Traeger A, Schubert US. The great escape: how cationic polyplexes overcome the endosomal barrier. J Materials Chem B. 2018;6(43):6904–6918. doi:10.1039/C8TB00967H
   PubMed Web of Science ®Google Scholar
• Yang S, May S. Release of cationic polymer-DNA complexes from the endosome: a theoretical investigation of the proton sponge hypothesis. J Chem Phys. 2008;129(18):185105. doi:10.1063/1.3009263
   PubMed Web of Science ®Google Scholar
• Cheng X, Lee RJ. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Adv Drug Deliv Rev. 2016;99:129–137. doi:10.1016/j.addr.2016.01.022
   PubMed Web of Science ®Google Scholar
• Granot Y, Peer D. Delivering the right message: challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint. Semin Immunol. 2017;34:68–77. doi:10.1016/j.smim.2017.08.015
   PubMed Web of Science ®Google Scholar
• Mui BL, Tam YK, Jayaraman M, et al. Influence of Polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol Therapy. 2013;2:e139. doi:10.1038/mtna.2013.66
   Web of Science ®Google Scholar
• Love KT, Mahon KP, Levins CG, et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc Nat Acad Sci. 2010;107(5):1864–1869. doi:10.1073/pnas.0910603106
   PubMed Web of Science ®Google Scholar
• Guatimosim S, Amaya MJ, Guerra MT, et al. Nuclear Ca2+ regulates cardiomyocyte function. Cell Calcium. 2008;44(2):230–242. doi:10.1016/j.ceca.2007.11.016
   PubMed Web of Science ®Google Scholar
• Otsu N, Threshold Selection A. Method from Gray-Level Histograms. IEEE Trans Syst Man Cybern. 1979;9(1):62–66. doi:10.1109/TSMC.1979.4310076
   Web of Science ®Google Scholar
• Heyes J, Palmer L, Bremner K, MacLachlan I. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J Controlled Release. 2005;107(2):276–287. doi:10.1016/j.jconrel.2005.06.014
   PubMed Web of Science ®Google Scholar
• O’Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267(17):5421–5426. doi:10.1046/j.1432-1327.2000.01606.x
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Krohn-Grimberghe M, Mitchell MJ, Schloss MJ, et al. Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche. Nat Biomed Eng. 2020;4(11):1076–1089. doi:10.1038/s41551-020-00623-7
   PubMed Web of Science ®Google Scholar
• Bass-Stringer S, Bernardo BC, May CN, Thomas CJ, Weeks KL, McMullen JR. Adeno-associated virus gene therapy: translational progress and future prospects in the treatment of heart failure. Heart Lung Circ. 2018;27(11):1285–1300. doi:10.1016/j.hlc.2018.03.005
   PubMed Web of Science ®Google Scholar
• Ylä-Herttuala S, Baker AH. Cardiovascular gene therapy: past, present, and future. Mol Therapy. 2017;25(5):1095–1106. doi:10.1016/j.ymthe.2017.03.027
   PubMed Web of Science ®Google Scholar
• Stewart DJ, Hilton JD, Arnold JMO, et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a Phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment. Gene Ther. 2006;13(21):1503–1511. doi:10.1038/sj.gt.3302802
   PubMed Web of Science ®Google Scholar
• Hedman M, Hartikainen J, Syvänne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia. Circulation. 2003;107(21):2677–2683. doi:10.1161/01.CIR.0000070540.80780.92
   PubMed Web of Science ®Google Scholar
• Flugelman MY, Halak M, Yoffe B, et al. Phase Ib safety, two-dose study of MultiGeneAngio in patients with chronic critical limb ischemia. Mol Therapy. 2017;25(3):816–825. doi:10.1016/j.ymthe.2016.12.019
   PubMed Web of Science ®Google Scholar
• Deev R. pCMV- vegf165 intramuscular gene transfer is an effective method of treatment for patients with chronic lower limb ischemia. J Cardiovasc Pharmacol Ther. 2015;20(5):473–482. doi:10.1177/1074248415574336
   PubMed Web of Science ®Google Scholar
• Kim Y, Zharkinbekov Z, Sarsenova M, Yeltay G, Saparov A. Recent advances in gene therapy for cardiac tissue regeneration. Int J Mol Sci. 2021;22(17):9206. doi:10.3390/ijms22179206
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Weber T, Hajjar RJ. Human cardiac gene therapy. Circ Res. 2018;123(5):601–613. doi:10.1161/CIRCRESAHA.118.311587
   PubMed Web of Science ®Google Scholar
• Shimamura M, Nakagami H, Sanada F, Morishita R. Progress of gene therapy in cardiovascular disease. Hypertension. 2020;76(4):1038–1044. doi:10.1161/HYPERTENSIONAHA.120.14478
   PubMed Web of Science ®Google Scholar
• Bezzerides VJ, Prondzynski M, Carrier L, Pu WT. Gene therapy for inherited arrhythmias. Cardiovasc Res. 2020;116(9):1635–1650. doi:10.1093/cvr/cvaa107
   PubMed Web of Science ®Google Scholar
• Tonelli FMP, Lacerda SMSN, Paiva NCO, et al. Functionalized nanomaterials: are they effective to perform gene delivery to difficult-to-transfect cells with no cytotoxicity? Nanoscale. 2015;7(43):18036–18043. doi:10.1039/C5NR04173B
   PubMed Web of Science ®Google Scholar
• Kauffman KJ, Dorkin JR, Yang JH, et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 2015;15(11):7300–7306. doi:10.1021/acs.nanolett.5b02497
   PubMed Web of Science ®Google Scholar
• Ermilova I, Swenson J. DOPC versus DOPE as a helper lipid for gene-therapies: molecular dynamics simulations with DLin-MC3-DMA. Physical Chem. 2020;22(48):28256–28268. doi:10.1039/D0CP05111J
   Web of Science ®Google Scholar
• Du Z, Munye MM, Tagalakis AD, Manunta MDI, Hart SL. The role of the helper lipid on the DNA transfection efficiency of lipopolyplex formulations. Sci Rep. 2015;4(1):7107. doi:10.1038/srep07107
   Web of Science ®Google Scholar
• Kim BK, Hwang GB, Seu YB, Choi JS, Jin KS, Doh KO. DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes. Biochim Biophys Acta. 2015;1848(10):1996–2001. doi:10.1016/j.bbamem.2015.06.020
   PubMed Web of Science ®Google Scholar
• Jayaraman M, Ansell SM, Mui BL, et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angewandte Chemie Int Edition. 2012;51(34):8529–8533. doi:10.1002/anie.201203263
   PubMed Web of Science ®Google Scholar
• Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021;16(3):266–276. doi:10.1038/s41565-021-00858-8
   PubMed Web of Science ®Google Scholar
• Song LY, Ahkong QF, Rong Q, et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta. 2002;1558(1):1–13. doi:10.1016/S0005-2736(01)00399-6
   PubMed Web of Science ®Google Scholar
• Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igyártó BZ. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience. 2021;24(12):103479. doi:10.1016/j.isci.2021.103479
   Google Scholar
• Verma AK, Lavine KJ, Lin CY. Myocarditis after Covid-19 mRNA vaccination. N Eng J Med. 2021;385(14):1332–1334. doi:10.1056/NEJMc2109975
   PubMed Web of Science ®Google Scholar
• Kulkarni JA, Myhre JL, Chen S, et al. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine. 2017;13(4):1377–1387. doi:10.1016/j.nano.2016.12.014
   PubMed Web of Science ®Google Scholar
• Sabnis S, Kumarasinghe ES, Salerno T, et al. A Novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol Therapy. 2018;26(6):1509–1519. doi:10.1016/j.ymthe.2018.03.010
   PubMed Web of Science ®Google Scholar